Resultados de procura - Plummer, Ruth

Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer? por Plummer, Ruth

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Cancer immunotherapy and its potential cardiac complications por Findlay, Simon G, Plummer, Ruth, Plummer, Chris

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Tremelimumab-Induced Graves Hyperthyroidism por Gan, Earn H., Mitchell, Anna L., Plummer, Ruth, Pearce, Simon, Perros, Petros

Ligazón do recurso Ligazón do recurso Ligazón do recurso

mTORC1 and DNA‐PKcs as novel molecular determinants of sensitivity to Chk1 inhibition por Massey, Andrew J., Stephens, Peter, Rawlinson, Rebecca, McGurk, Lauren, Plummer, Ruth, Curtin, Nicola J.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors por Plummer, Ruth, Stephens, Peter, Aissat-Daudigny, Louiza, Cambois, Anne, Moachon, Gilbert, Brown, Peter D., Campone, Mario

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Mechanisms of Chemoresistance in Malignant Glioma por Sarkaria, Jann N., Kitange, Gaspar J., James, C. David, Plummer, Ruth, Calvert, Hilary, Weller, Michael, Wick, Wolfgang

Ligazón do recurso Ligazón do recurso Ligazón do recurso

First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours por Ameratunga, Malaka, Braña, Irene, Bono, Petri, Postel-Vinay, Sophie, Plummer, Ruth, Aspegren, John, Korjamo, Timo, Snapir, Amir, de Bono, Johann S

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours:... por Cranston, Amy, Stocken, Deborah D., Stamp, Elaine, Roblin, David, Hamlin, Julia, Langtry, James, Plummer, Ruth, Ashworth, Alan, Burn, John, Rajan, Neil

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study por Brown, Jennifer, Plummer, Ruth, Bauer, Todd M., Anthony, Stephen, Sarantopoulos, John, De Vos, Filip, White, Mike, Schupp, Marco, Ou, Ying, Vaishampayan, Ulka

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours por Shapiro, Geoffrey I., Wesolowski, Robert, Devoe, Craig, Lord, Simon, Pollard, John, Hendriks, Bart S., Falk, Martin, Diaz-Padilla, Ivan, Plummer, Ruth, Yap, Timothy A.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours por Middleton, Mark R., Dean, Emma, Evans, Thomas R. J., Shapiro, Geoffrey I., Pollard, John, Hendriks, Bart S., Falk, Martin, Diaz-Padilla, Ivan, Plummer, Ruth

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer por Shaheen, Fadhel S., Znojek, Pawel, Fisher, Ann, Webster, Martin, Plummer, Ruth, Gaughan, Luke, Smith, Graeme C. M., Leung, Hing Y., Curtin, Nicola J., Robson, Craig N.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors por Plummer, Ruth, Madi, Ayman, Jeffels, Melinda, Richly, Heike, Nokay, Bahar, Rubin, Stephen, Ball, Howard A., Weller, Steve, Botbyl, Jeffrey, Gibson, Diana M., Scheulen, Max E.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965 por McNeillis, Rosie, Greystoke, Alastair, Walton, Jon, Bacon, Chris, Keun, Hector, Siskos, Alexandros, Petrides, George, Leech, Nicola, Jenkinson, Fiona, Bowron, Ann, Halford, Sarah, Plummer, Ruth

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965 por McNeillis, Rosie, Greystoke, Alastair, Walton, Jon, Bacon, Chris, Keun, Hector, Siskos, Alexandros, Petrides, George, Leech, Nicola, Jenkinson, Fiona, Bowron, Ann, Halford, Sarah, Plummer, Ruth

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study proto... por Menne, Tobias, Slade, Daniel, Savage, Joshua, Johnson, Sarah, Irving, Julie, Kearns, Pamela, Plummer, Ruth, Shenton, Geoff, Veal, Gareth J, Vormoor, Britta, Vormoor, Josef, Billingham, Lucinda

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine por Twelves, Chris, Anthoney, Alan, Savulsky, Claudio I., Guo, Matthew, Reyderman, Larisa, Cresti, Nicola, Semiglazov, Vladimir, Timcheva, Constanta, Zubairi, Ishtiaq, Morrison, Rosemary, Plummer, Ruth, Evans, T. R. Jeffry

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours por Wilson, Richard H, Evans, TR Jeffry, Middleton, Mark R, Molife, L Rhoda, Spicer, James, Dieras, Veronique, Roxburgh, Patricia, Giordano, Heidi, Jaw-Tsai, Sarah, Goble, Sandra, Plummer, Ruth

Ligazón do recurso Ligazón do recurso Ligazón do recurso

SARS-CoV-2 vaccination and phase 1 cancer clinical trials por Yap, Timothy A, Siu, Lillian L, Calvo, Emiliano, Lolkema, Martijn P, LoRusso, Patricia M, Soria, Jean-Charles, Plummer, Ruth, de Bono, Johann S, Tabernero, Josep, Banerji, Udai

Ligazón do recurso Ligazón do recurso Ligazón do recurso

First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor por Plummer, Ruth, Dua, Divyanshu, Cresti, Nicola, Drew, Yvette, Stephens, Peter, Foegh, Marie, Knudsen, Steen, Sachdev, Pallavi, Mistry, Bipin M., Dixit, Vaishali, McGonigle, Sharon, Hall, Nancy, Matijevic, Mark, McGrath, Shannon, Sarker, Debashis

Ligazón do recurso Ligazón do recurso Ligazón do recurso